Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Multiple Ascending Dose Study of LW402 in Healthy Volunteers
Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd.
Summary
This Phase 1, double-blind (sponsor open), placebo controlled study will assess the safety, tolerability and pharmacokinetics of multiple doses of LW402 tablets in healthy volunteers.
Official title: A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LW402 Tablets Following Multiple Doses in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2025-10-15
Completion Date
2025-12-31
Last Updated
2026-04-22
Healthy Volunteers
Yes
Conditions
Interventions
Experimental
LW402 Tablets
Placebo
LW402 Placebo Tablets
Locations (1)
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shangdong, China